These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 22793946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical profile of roflumilast].
    Izquierdo Alonso JL.
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():25-32. PubMed ID: 21316553
    [Abstract] [Full Text] [Related]

  • 4. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P, American College of Physicians, American College of Chest Physicians, American Thoracic Society, European Respiratory Society.
    Ann Intern Med; 2011 Aug 02; 155(3):179-91. PubMed ID: 21810710
    [Abstract] [Full Text] [Related]

  • 6. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct 02; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 7. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE, Shukla A, Muellerova H, Davis KJ.
    COPD; 2014 Sep 02; 11(5):521-30. PubMed ID: 24945236
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.
    Miravitlles M, D'Urzo A, Singh D, Koblizek V.
    Respir Res; 2016 Sep 10; 17(1):112. PubMed ID: 27613392
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN, Broeders ME, Tuut MK, Grol MH.
    Ned Tijdschr Geneeskd; 2008 Jun 28; 152(26):1465-8. PubMed ID: 18666664
    [Abstract] [Full Text] [Related]

  • 15. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D.
    Expert Opin Pharmacother; 2011 Aug 28; 12(12):1913-32. PubMed ID: 21714776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Emerging therapeutic strategies in COPD.
    Babu KS, Morjaria JB.
    Drug Discov Today; 2015 Mar 28; 20(3):371-9. PubMed ID: 25462534
    [Abstract] [Full Text] [Related]

  • 20. [Limitations of current treatment: unmet needs in the treatment of COPD].
    de Lucas Ramos P, López Martín S, Rodríguez González-Moro JM.
    Arch Bronconeumol; 2010 Dec 28; 46 Suppl 10():8-13. PubMed ID: 21316550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.